• Anlotinib hydrochloride in Angiogenesis Assays

  2026-08-13

  Build reproducible angiogenesis workflows around Anlotinib hydrochloride, from endothelial cell migration inhibition and capillary tube formation to receptor-phosphorylation analysis. The article translates a rare-tumor case report into practical assay design while separating mechanistic evidence from exploratory protocol recommendations.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody

  2026-08-13

  HRP Goat Anti-Rabbit IgG (H+L) Antibody provides an HRP-labeled detection reagent for rabbit primary antibodies in Western blotting, ELISA, IHC, and IC workflows. It is intended for research use only, with assay-specific validation required; it should not be used for diagnostic or medical applications.

• Prochlorperazine: D2 Antagonist Research Guide

  2026-08-12

  Prochlorperazine is a dopamine D2 receptor antagonist with established antiemetic relevance and experimentally studied antiviral and melanoma-related effects. The evidence supports controlled in vitro research use, while the acute mountain sickness application remains under randomized clinical evaluation.

• KX2-391 dihydrochloride in Src Research

  2026-08-12

  KX2-391 dihydrochloride, also called Tirbanibulin dihydrochloride, supports mechanism-resolved studies of Src signaling, tubulin dynamics, HBV transcription, and BoNT/A activity. Its strongest use-case is a staged workflow that combines high-content phenotyping with genotype-aware validation rather than relying on a single viability endpoint.

• Plk1 Control of p31comet in Mitotic Checkpoint Exit

  2026-08-11

  This study identifies Polo-like kinase 1 (Plk1) as a direct regulator of p31comet-mediated mitotic checkpoint complex disassembly. By phosphorylating p31comet at S102, Plk1 suppresses the TRIP13-dependent release of Mad2, providing a mechanism that prevents premature checkpoint inactivation during mitosis.

• PINK1 Loss, Mitochondrial Iron, and Colon Tumorigenesis

  2026-08-10

  The reference study identifies mitochondrial iron accumulation as a functional vulnerability created by PINK1 deficiency in colorectal tumors. By combining transcriptomics, iron and reactive oxygen species measurements, pharmacological perturbation, and MCU manipulation, the authors connect impaired mitophagy to tumor growth and propose iron-lowering strategies for tumors with low PINK1 expression.

• Cannabidiol and Orofacial Inflammatory Pain

  2026-08-09

  This 2026 Brain Research Bulletin study shows that cannabidiol (CBD) acts across peripheral and central pathways to reduce orofacial inflammatory pain while improving pain-related affective and cognitive deficits in mice. Its combination of behavioral phenotyping, molecular profiling, and in vivo fiber photometry provides a useful framework for studying multi-dimensional pain regulation and evaluating translational limitations.

• 3-Deazaneplanocin (DZNep): A Mechanism-First Guide

  2026-08-08

  Explore how 3-Deazaneplanocin (DZNep) connects SAHH inhibition, EZH2 depletion, and context-dependent epigenetic responses. This guide translates oncology and metabolic disease evidence into better assay design and interpretation.

• TAK-242: TLR4 Control in Heatstroke Neuroinflammation

  2026-08-07

  TAK-242 (Resatorvid) provides a precise way to interrogate TLR4-driven inflammation beyond routine cytokine assays. This article interprets heatstroke-brain injury evidence to show how pathway inhibition, microglial polarization, and functional endpoints can be integrated into stronger neuroinflammation research designs.

• iPSC-Based Platform Advances CF Drug Screening and Genotype

  2026-08-07

  This study introduces a multimodal platform using induced pluripotent stem cell (iPSC)-derived airway epithelial cells to model cystic fibrosis (CF) across common and rare CFTR variants. The approach enables genotype-specific drug testing and functional analysis, marking a significant advance for preclinical evaluation of CF therapies.

• Diuron Impairs Osteogenic Differentiation via PI3K/Akt Suppr

  2026-08-06

  This paper provides the first in-depth in vitro evidence that diuron, a persistent environmental herbicide, impairs human bone marrow mesenchymal stem cell (BMSC) viability and osteogenic differentiation by suppressing PI3K/Akt pathway signaling. The findings highlight a mechanistic link between environmental toxicants and bone health, with implications for osteoporosis risk assessment.

• Stiripentol: LDH Inhibition for Next-Gen Translational Resea

  2026-08-06

  Explore how Stiripentol, a novel LDH inhibitor, empowers translational researchers to dissect and manipulate metabolic and epigenetic mechanisms in epilepsy and immunometabolism. This article bridges mechanistic insights—such as astrocyte-neuron lactate shuttle modulation and histone lactylation—with actionable guidance for experimental design, protocol optimization, and future clinical translation, extending well beyond traditional product overviews.

• CF10 and EdU Synergy Drives Telomere Attrition in CRC Cells

  2026-08-05

  The reference study demonstrates that combining the fluoropyrimidine polymer CF10 with EdU induces profound telomere attrition and mitotic catastrophe in colorectal cancer cells, surpassing the effects of standard 5-FU combinations. These findings offer mechanistic insights into how enforced telomere shortening and DNA damage can synergistically inhibit cancer cell proliferation and suggest new avenues for telomerase-targeted therapy.

• hiPSC-Derived Intestinal Organoids Advance Drug PK Modeling

  2026-08-05

  Saito et al. established a streamlined method for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) capable of maturing into absorptive and metabolic intestinal epithelial cells. This model offers improved relevance for pharmacokinetic studies of orally administered drugs compared to traditional animal and cancer cell line approaches, with key implications for drug discovery workflows.

• Prednisolone (SKU B2012): Reliable Choice for Glucocorticoid

  2026-08-04

  This article delivers an evidence-based guide for deploying Prednisolone (SKU B2012) in cell viability, proliferation, and cytotoxicity workflows. Scenario-driven Q&A blocks address real-world experimental challenges, with practical insights on formulation, reproducibility, and vendor selection. By integrating validated protocol parameters and referencing peer-reviewed literature, biomedical researchers gain actionable solutions for consistent results.

449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page